RecallDepth
Class II Terminated

Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202 NDC: 68180-658-06

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
July 28, 2022
Posted
August 24, 2022
Recall Number
D-1343-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7,872/30 count bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

Distribution

Product was distributed nationwide.

Lot / Code Info

Lot #A200170, exp. date December 2023

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls